Loading clinical trials...
Loading clinical trials...
Effect of Calcipotriol Plus Hydrocortisone Ointment on the Hypothalamic-pituitary-adrenal (HPA) Axis and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and on the Intertriginous Areas
Conditions
Interventions
Calcipotriol plus hydrocortisone (LEO 80190)
Locations
11
United States
Burke Pharmaceuticals
Hot Springs, Arkansas, United States
Dermatology Research of Arkansas
Little Rock, Arkansas, United States
Ameriderm Research
Ormond Beach, Florida, United States
Somerset Skin Center
Troy, Michigan, United States
Psoriasis Treatment Center of Central NJ
East Windsor, New Jersey, United States
Virginia Clinical Research, Inc.
Norfolk, Virginia, United States
Start Date
May 1, 2008
Primary Completion Date
December 1, 2009
Completion Date
December 1, 2009
Last Updated
March 7, 2025
NCT04080635
NCT04340076
NCT03507946
NCT06191042
NCT05215561
NCT04099979
Lead Sponsor
LEO Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions